Streamline Clinical Development with AI
Introducing Neuroute, Clinical Development Powered by AI
Designed for life science startups. Accelerate the full clinical research workflow
Active Now
Streamline Clinical Development with AI
Introducing Neuroute, Clinical Development Powered by AI
Designed for life science startups. Accelerate the full clinical research workflow
Active Now
Streamline Clinical Development with AI
Introducing Neuroute, Clinical Development Powered by AI
Designed for life science startups. Accelerate the full clinical research workflow
Active Now
No-Code AI for Clinical Research
No-Code AI for Clinical Research
Modus - Immunoglycan for Sepsis
Modus aims to save countless lives using an immunoglycan, Sevuparin, that thins the blood to prevent blood clots without the risk of unwanted bleeding.
Sites Analyzed
174
Studies Analyzed
7,010
Modus - Immunoglycan for Sepsis
Modus aims to save countless lives using an immunoglycan, Sevuparin, that thins the blood to prevent blood clots without the risk of unwanted bleeding.
Indications
8
Studies Analyzed
1,790
Psyrin - Serious mental illness
Psyrin detects serious mental illnesses through AI-powered voice technology. SMIs affect over 145 million people worldwide, reducing expected life expectancy by 15-20 years.
Patient Cohorts
12
Studies Analyzed
4,809
Psyrin - Serious mental illness
Psyrin detects serious mental illnesses through AI-powered voice technology. SMIs affect over 145 million people worldwide, reducing expected life expectancy by 15-20 years.
Indications
150%
Studies Analyzed
1,790
Li Ka Shing Institute of Health Sciences
Scoping the potential of clinical development across indications and countries including Hong Kong, China and the UK.
Indications
21
Studies Analyzed
9,500
Li Ka Shing Institute of Health Sciences
Scoping the potential of clinical development across indications and countries including Hong Kong, China and the UK.
Indications
8
Studies Analyzed
1,790
Collaboration Made Seamless
AI-powered data analytics, empowering your team to make precise, data-driven decisions. Accelerates clinical development, ensuring medicines reach patients more efficiently and effectively.
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
Collaboration Made Seamless
AI-powered data analytics, empowering your team to make precise, data-driven decisions. Accelerates clinical development, ensuring medicines reach patients more efficiently and effectively.
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
Collaboration Made Seamless
AI-powered data analytics, empowering your team to make precise, data-driven decisions. Accelerates clinical development, ensuring medicines reach patients more efficiently and effectively.
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
01
Patient Access
Compare Patient Access by Region. Decide on optimal site locations with patient demographic, study and site analytics
Landscape Analysis
Assess historical studies by randomization rate. Understand the drivers of studies with high RAND rates and incorporate them into your own.
02
Site Selection
Analyze sites by performance, capacity, competition and specificity. Decide which sites are relevant based on past studies and current studies that could be competing
03
Model Enrollment
Produce time estimates based off of historical data. Model enrollment scenarios with varying numbers of sites and patients in different geographies.
04
Designed for Life Science Startups
Since 2019, the world’s best companies have depended on Neuroute to build better patient experiences for their studies.
"In partnership with neuroute, we can really change things to the benefit of the patients who still desperately need new and improved medicines."
Dr. Mike Emanuel // Former Head of Clinical Development
"In partnership with neuroute, we can really change things to the benefit of the patients who still desperately need new and improved medicines."
Dr. Mike Emanuel // Former Head of Clinical Development
"In partnership with neuroute, we can really change things to the benefit of the patients who still desperately need new and improved medicines."
Dr. Mike Emanuel // Former Head of Clinical Development
Unleash seamless team collaboration, data-driven
clinical planning, and efficient clinical development
Patient Population Analysis
Competitive Landscape
Country Selection
Indication Analysis
Literature Reviews
Protocol Development
Landscape Analysis
Site Selection
Feasibility
Study Design
Site Initiation
QMS
AI-Generated
No-Code
Unleash seamless team collaboration, data-driven
clinical planning, and efficient clinical development
Patient Population Analysis
Competitive Landscape
Country Selection
Indication Analysis
Literature Reviews
Protocol Development
Landscape Analysis
Site Selection
Feasibility
Study Design
Site Initiation
QMS
AI-Generated
No-Code
Unleash seamless team collaboration, data-driven
clinical planning, and efficient clinical development
Patient Population Analysis
Competitive Landscape
Country Selection
Indication Analysis
Literature Reviews
Protocol Development
Landscape Analysis
Site Selection
Feasibility
Study Design
Site Initiation
QMS
AI-Generated
No-Code
Explore Access
If you believe AI is the future of clinical development, let's talk.
Explore Access
If you believe AI is the future of clinical development, let's talk.
